← Open Payments lookup

CATHERINE MCNAMARA: Open Payments

NPI 1649364613 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 40 payments from 14 companies in 2025. Trend: 2023 $1,066 · 2024 $972 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$156
ABBVIE INC.6$130
PFIZER INC.5$126
Astellas Pharma US Inc3$101
Novo Nordisk Inc4$96
Lilly USA, LLC4$86
Amgen Inc.3$74
Sumitomo Pharma America, Inc.2$50
GlaxoSmithKline, LLC.2$33
Corcept Therapeutics1$28

Products named: Veozah, NURTEC ODT, VRAYLAR, MOUNJARO, FARXIGA, BREZTRI, Ozempic, GEMTESA.

Industry payments across NV — which companies pay providers there.